Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Mark Brosius sold 46 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 18th. The shares were sold at an average price of $430.63, for a total value of $19,808.98. Following the transaction, the executive vice president directly owned 319 shares in the company, valued at approximately $137,370.97. The trade was a 12.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Monday, November 16th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $444.38, for a total value of $20,441.48.
- On Wednesday, October 28th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The shares were sold at an average price of $441.60, for a total value of $26,937.60.
- On Monday, October 26th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The shares were sold at an average price of $451.75, for a total value of $27,556.75.
- On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $365.79, for a total value of $9,144.75.
- On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $350.20, for a total transaction of $8,054.60.
- On Tuesday, September 8th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $361.23, for a total transaction of $16,616.58.
- On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89.
Intuitive Surgical Price Performance
Shares of ISRG stock opened at $420.95 on Thursday. The firm has a 50-day moving average of $421.98 and a 200-day moving average of $428.75. The company has a market cap of $145.92 billion, a P/E ratio of 50.90, a P/E/G ratio of 2.97 and a beta of 1.45. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same period last year, the firm earned $2.40 earnings per share. The firm’s revenue was up 21.7% on a year-over-year basis. As a group, research analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Intuitive Surgical
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Fi3 FINANCIAL ADVISORS LLC lifted its holdings in Intuitive Surgical by 19.1% during the third quarter. Fi3 FINANCIAL ADVISORS LLC now owns 1,002 shares of the medical equipment provider’s stock valued at $407,000 after purchasing an additional 161 shares during the last quarter. Heartland Bank & Trust Co boosted its position in Intuitive Surgical by 4.7% during the third quarter. Heartland Bank & Trust Co now owns 2,082 shares of the medical equipment provider’s stock worth $847,000 after purchasing an additional 94 shares during the period. Harbor Advisors LLC bought a new position in Intuitive Surgical during the third quarter worth about $203,000. Innovator Capital Management LLC purchased a new position in shares of Intuitive Surgical in the third quarter worth about $7,982,000. Finally, Brown Financial Advisors raised its position in shares of Intuitive Surgical by 25.5% in the third quarter. Brown Financial Advisors now owns 2,877 shares of the medical equipment provider’s stock valued at $1,170,000 after purchasing an additional 584 shares during the period. 83.64% of the stock is currently owned by institutional investors.
Recent Intuitive Surgical Headlines
Investors following ISRG have been watching these headlines:
- Positive Sentiment: BTIG Research raised its price target to $513 from $454 and reiterated a “buy” rating, citing potential upside. BTIG Research rating information
- Neutral Sentiment: EVP Mark Brosius reported sales totaling 92 shares across two transactions, worth about $40,250. Both were made under a pre-arranged Rule 10b5-1 plan, and the small size makes them a limited signal about management’s view of the stock. SEC insider-trading filing
- Negative Sentiment: A valuation-focused analysis argues ISRG may be near fair value despite revenue growth, pointing to competitive pressure and new robotic platforms. That may temper enthusiasm for the shares after their longer-term gains. Valuation and competition analysis
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the company. BNP Paribas Exane raised Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Wednesday, October 21st. Royal Bank Of Canada dropped their price target on Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a report on Wednesday, October 21st. Robert W. Baird boosted their price objective on Intuitive Surgical from $513.00 to $550.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 21st. Finally, UBS Group restated a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 13th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $495.90.
View Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
See Also
- Five stocks we like better than Intuitive Surgical
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
